ISRCTN62219234已完成未知
Changing illness perceptions: a randomised controlled trial of a psychological, family-based intervention to improve outcomes in type 2 diabetes
Health Research Board (Ireland)0 个研究点目标入组 121 人开始时间: 2007年4月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 121
研究概览
简要总结
- 2007 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/17597523 2. 2011 results in: https://www.ncbi.nlm.nih.gov/pubmed/21473660 (added 16/05/2019)
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Have type 2 diabetes for more than one year, and at least two out of their last three HbA1c readings have been 8.0% or over, in order to identify patients with persistent poor control
- •2. Over 18 years of age
- •3. Have fluency in English
排除标准
- •Patients with a significant mental or physical illness, as determined by the patients? clinician, will be excluded. ?Significant mental or physical illness ?is defined as any illness that is thought likely to impair the patient?s capacity to change their lifestyle behaviour or assimilate new information.
研究者
相似试验
已完成
不适用
Changing illness perceptions of patients with intermittent claudicatioISRCTN28051878niversity of Stirling (UK)80
已完成
4 期
Symptoms and Physiological Effects of Amara in Functional DyspepsiaDyspepsiaNCT05553587Mark Fox60
进行中（未招募）
不适用
An Exploratory Study to Evaluate Changes in Disease Activity and Biomarkers During Treatment With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE). Final Protocol dated 2009-03-16. Protocol Amendment 1 dated 2009-10-13. Protocol Amendment 2 dated 2009-12-02EUCTR2009-011245-55-DKActive Biotech Research AB20
进行中（未招募）
不适用
An Exploratory Study to Evaluate Changes in Disease Activity and Biomarkers During Treatment With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE). Final Protocol dated 2009-03-16, Protocol Amendment 1 dated 2009-10-13, Protocol Amendment 2 dated 2009-12-02Systemic Lupus Erythematosus (SLE)EUCTR2009-011245-55-SEActive Biotech Research AB20
已完成
2 期
An Evaluation of the Effectiveness of a Proprietary Probiotic Blend on Functional ConstipationFunctional ConstipationNCT02418507KGK Science Inc.100